1 / 6

Hemoglobinopathies Market : Predictable to Demand Drivers | 2023

The hemoglobinopathies market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 5,800 million in 2018 and is projected to register a CAGR of around10.2% over the forecast period.<br>

vinitsawant6675
Download Presentation

Hemoglobinopathies Market : Predictable to Demand Drivers | 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Hemoglobinopathies Market Global Industry Survey, Growth, Competitive Landscapeand Forecasts to 2023 CREATED BY Market Research Future (Part of Wantstats Research & Media Pvt. Ltd.)

  2. Hemoglobinopathies Market Global Research Report - Forecast till 2023 Market Insights: According to Market Research Future (MRFR), the global hemoglobinopathies market is projected to rise significantly over the forecast period. The market held a valuation of USD 5.800 million in 2018 and is predicted to experience a CAGR of about 10.2% from 2019 to 2025 (forecast period). The report provides a comprehensive overview of the present scenario, the economic condition, and the COVID-19 analysis of the overall market. Hemoglobinopathy is a group of blood disorders such as sickle cell disease, thalassemia, and many others. It is considered the most common genetic disorder in the world. Hemoglobinopathies have also become much more prevalent in central and northern Europe, like Germany, due to immigration. Market Dynamics The increased incidence of hemoglobin disorders such as sickle cell anemia, thalassemia, Hb C, and Hb E is expected to be a high-impact market factor. As per the WHO, hemoglobin disorders are prevalent in more than 60% of the 229 countries, with over 70% of births. As per the study published by the Centers for Disease Control and Prevention ( CDC) in 2015, the initial screening of newborns for the diagnosis of sickle cell disease (SCD) and other hemoglobin disorders such as alpha (α) and beta (β) thalassemia has also earned considerable attention in recent years due to changes in US demographics. www.marketresearchfuture.com

  3. Hemoglobinopathies Market Global Research Report - Forecast till 2023 Segmentation Analysis The global market for hemoglobinopathies has been segmented based on type, treatment, and end-users. By type, the global market for hemoglobinopathies has been segmented into thalassemia, sickle cell disease, and other Hb variants diseases. Thalassemia is further classified as alpha-thalassemia and beta-thalassemia. The sickle cell disease segment is projected to hold the largest market share of the hemoglobinopathies market. This is due to the existence of robust product pipelines such as Lent Globin and the rising prevalence of sickle cell disease. Based on treatment, the global market for hemoglobinopathies has been classified into stem-cell transplantation, blood transfusions, analgesics, antibiotics, ACE inhibitors, and hydroxyurea. The blood transfusion segment holds the largest market share due to a high success rate and the increased acceptance of this treatment option. By the end-user, the global market for hemoglobinopathies has been classified into hospitals and clinics, diagnostics laboratories, and others. Get Sample Report: https://www.marketresearchfuture.com/sample_request/8098 www.marketresearchfuture.com

  4. Hemoglobinopathies Market Global Research Report - Forecast till 2023 Application & Major Players in this Research: Some of key the players in the market are • Sanofi • Sangamo Therapeutics, Inc. • Global Blood Therapeutics • Neusoft Medical Systems Co., Ltd • Bluebird Bio, Inc. • Emmaus Life Sciences Inc. • Prolong Pharmaceuticals • Celgene Corporation • Alnylam Pharmaceuticals • Gamida Cell To Read Full Report @ https://www.marketresearchfuture.com/reports/hemoglobinopathies-market-8098 www.marketresearchfuture.com

  5. Hemoglobinopathies Market Global Research Report - Forecast till 2023 About Us: Market Research Future At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. For more information kindly visit www.marketresearchfuture.com or contact us at info@marketresearchfuture.com Copyright © 2018 Market Research Future All Rights Reserved. This document contains highly confidential information and is the sole property of Market Research Future. No part of it may be circulated, copied, quoted, or otherwise reproduced without the written approval of Market Research Future. www.marketresearchfuture.com

  6. MARKET RESEARCH FUTURE THANK YOU salesteam@marketresearchfuture.com Ph: +1-646-845-9349 (US) Ph: +44 208 133 9349 (UK) www.marketresearchfuture.com

More Related